Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01040221 · ClinicalTrials.gov registry record · Phase 1
Trichuris Suis Ova in Autism Spectrum Disorders
A Phase 1 study of Autism, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01040221: Completed Phase 1 study of Autism, sponsored by Montefiore Medical Center.
NCT01040221 is a Phase 1 study of Autism that has completed, run by Montefiore Medical Center. The registered enrollment target is 10 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01040221, a Phase 1 study of Autism, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether Trichuris Suis Ova (TSO) is safe and effective in treating adults with autism spectrum disorder
Conditions Studied
Interventions
- DRUG Trichuris Suis Ova
Study Locations (1)
New York
- Montefiore Medical Center, Albert Einstein College of Medicine - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-07 |
| Phase | Phase 1 |
What the finished NCT01040221 record still lists
NCT01040221 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Trichuris Suis Ova is the first listed.
NCT01040221 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01040221 about?
NCT01040221 is a clinical study titled "Trichuris Suis Ova in Autism Spectrum Disorders". The purpose of this study is to determine whether Trichuris Suis Ova (TSO) is safe and effective in treating adults with autism spectrum disorder
What is the current status of trial NCT01040221?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2012-11. Estimated completion is 2014-07.
What conditions does trial NCT01040221 study?
This clinical trial studies the following conditions: Autism.
What interventions are being tested in trial NCT01040221?
The interventions under investigation include: Trichuris Suis Ova (DRUG).
Who is sponsoring clinical trial NCT01040221?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01040221 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01040221's enrollment target sits among peer trials
10 102nd of 104 higher than 2 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study
RECRUITING · Phase 1
-
An Autism Study Using Nambudripad's Food Allergy Elimination Treatments
COMPLETED · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia